Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of MCV4 on Meningococcal Carriage
NCT00119080Phase 4Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Aug 2006
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 4, randomised, open-label trial of meningococcal A conjugate vaccine in meningococcal meningitis (2 arms), sponsored by Centers for Disease Control and Prevention. Primary endpoint: Prevalence of asymptomatic nasopharyngeal carriage of meningococci serogroup Y at 9 months. Started Aug 2006; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT00119080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00119080.